JAVIER
PUENTE VÁZQUEZ

Profesor asociado

Foto de JAVIER

Foto de Hospital Universitario Virgen de la Victoria

Hospital Universitario Virgen de la Victoria

Málaga, España

Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (5)

2024

Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer
Cancers, Vol. 16, Núm. 14
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study
European urology oncology, Vol. 7, Núm. 3, pp. 447-455

2020

HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies
Annals of Oncology, Vol. 31, Núm. 9, pp. 1186-1197

2017

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study
Annals of Oncology, Vol. 28, Núm. 7, pp. 1-9

2010

Practical prognostic index for patients with metastatic recurrent breast cancer: Retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register
Breast Cancer Research and Treatment, Vol. 122, Núm. 2, pp. 591-600